FDA Inspection 1099882 — Kaleo, Inc.
The FDA completed an inspection of Kaleo, Inc. on July 31, 2019 in Richmond, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Richmond, VA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)